Clinical Trial Update: Combination Therapy for Recurrent Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combination therapy trial for recurrent ovarian cancer is currently recruiting in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Sham Sunder Kakar | Conditions: Recurrent Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING